FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988549331> ?p ?o ?g. }

• W1988549331 abstract "Severe hypoglycaemia still represents a significant problem in insulin-treated diabetes. Most patients do not experience severe hypoglycaemia often. However, 20% of patients with type 1 diabetes experience recurrent severe hypoglycaemia corresponding to at least two episodes per year. The effect of insulin analogues on glycaemic control has been documented in large trials, while their effect on the frequency of severe hypoglycaemia is less clear, especially in patients with recurrent severe hypoglycaemia. The HypoAna Trial is designed to investigate whether short-acting and long-acting insulin analogues in comparison with human insulin are superior in reducing the occurrence of severe hypoglycaemic episodes in patients with recurrent hypoglycaemia. This paper reports the study design of the HypoAna Trial.The study is a Danish two-year investigator-initiated, prospective, randomised, open, blinded endpoint (PROBE), multicentre, cross-over trial investigating the effect of insulin analogues versus human insulin on the frequency of severe hypoglycaemia in subjects with type 1 diabetes. Patients are randomised to treatment with basal-bolus therapy with insulin detemir / insulin aspart or human NPH insulin / human regular insulin in random order. The major inclusion criterion is history of two or more episodes of severe hypoglycaemia in the preceding year.In contrast to almost all other studies in this field the HypoAna Trial includes only patients with major problems with hypoglycaemia. The HypoAna Trial will elucidate whether basal-bolus regimen with short-acting and long-acting insulin analogues in comparison with human insulin are superior in reducing occurrence of severe hypoglycaemic episodes in hypoglycaemia prone patients with type 1 diabetes. http://www.clinicaltrials.gov: NCT00346996." @default.
• W1988549331 created "2016-06-24" @default.
• W1988549331 creator A5011991205 @default.
• W1988549331 creator A5022699151 @default.
• W1988549331 creator A5026845633 @default.
• W1988549331 creator A5045398531 @default.
• W1988549331 creator A5062023106 @default.
• W1988549331 creator A5066686056 @default.
• W1988549331 creator A5070884818 @default.
• W1988549331 creator A5074997674 @default.
• W1988549331 creator A5089441654 @default.
• W1988549331 creator A5090039776 @default.
• W1988549331 date "2012-06-22" @default.
• W1988549331 modified "2023-10-07" @default.
• W1988549331 title "A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design" @default.
• W1988549331 cites W1972763818 @default.
• W1988549331 cites W1983664900 @default.
• W1988549331 cites W1994735607 @default.
• W1988549331 cites W1999804954 @default.
• W1988549331 cites W2007204858 @default.
• W1988549331 cites W2007605927 @default.
• W1988549331 cites W2012686172 @default.
• W1988549331 cites W2015732159 @default.
• W1988549331 cites W2066807346 @default.
• W1988549331 cites W2072040332 @default.
• W1988549331 cites W2075086954 @default.
• W1988549331 cites W2075361652 @default.
• W1988549331 cites W2082848156 @default.
• W1988549331 cites W2083169504 @default.
• W1988549331 cites W2083824819 @default.
• W1988549331 cites W2087712389 @default.
• W1988549331 cites W2089597695 @default.
• W1988549331 cites W2100438391 @default.
• W1988549331 cites W2111938541 @default.
• W1988549331 cites W2122975542 @default.
• W1988549331 cites W2127636515 @default.
• W1988549331 cites W2129121181 @default.
• W1988549331 cites W2155489246 @default.
• W1988549331 cites W2162864009 @default.
• W1988549331 cites W2164850072 @default.
• W1988549331 cites W2190748907 @default.
• W1988549331 cites W2473786944 @default.
• W1988549331 cites W331952673 @default.
• W1988549331 cites W4243239489 @default.
• W1988549331 cites W4250647894 @default.
• W1988549331 cites W4379050932 @default.
• W1988549331 doi "https://doi.org/10.1186/1472-6823-12-10" @default.
• W1988549331 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3433358" @default.
• W1988549331 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22727048" @default.
• W1988549331 hasPublicationYear "2012" @default.
• W1988549331 type Work @default.
• W1988549331 sameAs 1988549331 @default.
• W1988549331 citedByCount "17" @default.
• W1988549331 countsByYear W19885493312013 @default.
• W1988549331 countsByYear W19885493312014 @default.
• W1988549331 countsByYear W19885493312015 @default.
• W1988549331 countsByYear W19885493312016 @default.
• W1988549331 countsByYear W19885493312017 @default.
• W1988549331 countsByYear W19885493312018 @default.
• W1988549331 countsByYear W19885493312019 @default.
• W1988549331 countsByYear W19885493312021 @default.
• W1988549331 countsByYear W19885493312022 @default.
• W1988549331 crossrefType "journal-article" @default.
• W1988549331 hasAuthorship W1988549331A5011991205 @default.
• W1988549331 hasAuthorship W1988549331A5022699151 @default.
• W1988549331 hasAuthorship W1988549331A5026845633 @default.
• W1988549331 hasAuthorship W1988549331A5045398531 @default.
• W1988549331 hasAuthorship W1988549331A5062023106 @default.
• W1988549331 hasAuthorship W1988549331A5066686056 @default.
• W1988549331 hasAuthorship W1988549331A5070884818 @default.
• W1988549331 hasAuthorship W1988549331A5074997674 @default.
• W1988549331 hasAuthorship W1988549331A5089441654 @default.
• W1988549331 hasAuthorship W1988549331A5090039776 @default.
• W1988549331 hasBestOaLocation W19885493311 @default.
• W1988549331 hasConcept C126322002 @default.
• W1988549331 hasConcept C134018914 @default.
• W1988549331 hasConcept C168563851 @default.
• W1988549331 hasConcept C187212893 @default.
• W1988549331 hasConcept C188816634 @default.
• W1988549331 hasConcept C203092338 @default.
• W1988549331 hasConcept C2777180221 @default.
• W1988549331 hasConcept C2779306644 @default.
• W1988549331 hasConcept C2779908123 @default.
• W1988549331 hasConcept C2779920387 @default.
• W1988549331 hasConcept C2780668416 @default.
• W1988549331 hasConcept C2780677441 @default.
• W1988549331 hasConcept C2781232474 @default.
• W1988549331 hasConcept C535046627 @default.
• W1988549331 hasConcept C555293320 @default.
• W1988549331 hasConcept C71924100 @default.
• W1988549331 hasConceptScore W1988549331C126322002 @default.
• W1988549331 hasConceptScore W1988549331C134018914 @default.
• W1988549331 hasConceptScore W1988549331C168563851 @default.
• W1988549331 hasConceptScore W1988549331C187212893 @default.
• W1988549331 hasConceptScore W1988549331C188816634 @default.
• W1988549331 hasConceptScore W1988549331C203092338 @default.
• W1988549331 hasConceptScore W1988549331C2777180221 @default.
• W1988549331 hasConceptScore W1988549331C2779306644 @default.
• W1988549331 hasConceptScore W1988549331C2779908123 @default.
• W1988549331 hasConceptScore W1988549331C2779920387 @default.

• next